CampaMed Exec Receives Patent For C-Med-100CampaMed Exec Receives Patent For C-Med-100

CampaMed Exec Receives Patent For C-Med-100

HILLSIDE, N.J.--Ronald Pero, chief scientific officer with CampaMed, has been issuedU.S. Patent #6,039,949 for C-MED-100 cat's claw. The ingredient is distributed exclusivelyby M.W. International Inc., a raw materials supplier based here. C-MED-100 is aproprietary extract of cat's claw (Uncaria tomentosa) with benefits to the immunesystem and DNA repair. For more information, see www.mwinternational.com.